Pancreatic Cancer Research

ResearcherUniversity of CopenhagenActive in the last 2 years

Stine F. Pedersen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3044-7714; OpenAlex author ID A5015579145, A5067705292. Sources: OpenAlex.

Their work

Papers
17 (first author 1, last author 8)
Trials
0
Grants
0
Labs led
1
Collaborators
41
Papers, trials and grants by year

2014: 1 paper · 2015: 3 papers · 2016: 2 papers · 2017: 1 paper · 2018: none · 2019: none · 2020: 2 papers · 2021: 1 paper · 2022: 2 papers · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper · 2026: 2 papers

Papers 17

  1. Microenvironmental acidosis drives PARP- and ATM inhibitor resistance in p53 deficient pancreatic cancer. Last author DOI 10.1016/j.isci.2026.115112↗
  2. pH-Dependent Microenvironmental Ionic Signaling in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1111/apha.70183↗
  3. Tumor microenvironment acidosis favors pancreatic cancer stem cell properties and in vivo metastasis. Last author DOI 10.1016/j.isci.2025.111956↗
  4. Adaptation to an acid microenvironment promotes pancreatic cancer organoid growth and drug resistance. Co-author DOI 10.1016/j.celrep.2024.114409↗
  5. Crosstalk between tumor acidosis, p53 and extracellular matrix regulates pancreatic cancer aggressiveness. Last author DOI 10.1002/ijc.34367↗
  6. Acid Adaptation Promotes TRPC1 Plasma Membrane Localization Leading to Pancreatic Ductal Adenocarcinoma Cell Proliferation and Migration through Ca2+ Entry and… Co-author DOI 10.3390/cancers14194946↗
  7. The TRPC1 Channel Forms a PI3K/CaM Complex and Regulates Pancreatic Ductal Adenocarcinoma Cell Proliferation in a Ca2+-Independent Manner. Co-author DOI 10.3390/ijms23147923↗
  8. Metabolic reprogramming by driver mutation-tumor microenvironment interplay in pancreatic cancer: new therapeutic targets. Co-author DOI 10.1007/s10555-021-10004-4↗
  9. TGFβ Signaling Increases Net Acid Extrusion, Proliferation and Invasion in Panc-1 Pancreatic Cancer Cells: SMAD4 Dependence and Link to Merlin/NF2 Signaling. Last author DOI 10.3389/fonc.2020.00687↗
  10. The Vacuolar H+ ATPase α3 Subunit Negatively Regulates Migration and Invasion of Human Pancreatic Ductal Adenocarcinoma Cells. Last author DOI 10.3390/cells9020465↗
  11. Alternating pH landscapes shape epithelial cancer initiation and progression: Focus on pancreatic cancer. Co-author DOI 10.1002/bies.201600253↗
  12. Monocarboxylate Transporters MCT1 and MCT4 Regulate Migration and Invasion of Pancreatic Ductal Adenocarcinoma Cells. Last author DOI 10.1097/mpa.0000000000000571↗
  13. Assessment of different 3D culture systems to study tumor phenotype and chemosensitivity in pancreatic ductal adenocarcinoma. Co-author DOI 10.3892/ijo.2016.3513↗
  14. ANO1 (TMEM16A) in pancreatic ductal adenocarcinoma (PDAC). Co-author DOI 10.1007/s00424-014-1598-8↗
  15. Corrigendum: Acid-base transport in pancreatic cancer: Molecular mechanisms and clinical potential. Last author DOI 10.1139/bcb-2015-0026↗
  16. The P2X7 receptor regulates cell survival, migration and invasion of pancreatic ductal adenocarcinoma cells. First author DOI 10.1186/s12943-015-0472-4↗
  17. Acid-base transport in pancreatic cancer: molecular mechanisms and clinical potential. Last author DOI 10.1139/bcb-2014-0078↗

Closest collaborators

The 25 strongest of 41 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Renata Ialchina · 6 shared papers, 2021–2026 · strength 1.24
  2. Albin Sandelin · 5 shared papers, 2023–2026 · strength 1.05
  3. Dominika Czaplińska · 4 shared papers, 2021–2026 · strength 0.83
  4. Henriette Berg Andersen · 4 shared papers, 2021–2026 · strength 0.83
  5. Ivana Novak · 8 shared papers, 2014–2026 · strength 0.75
  6. Arnaud Stigliani · 3 shared papers, 2023–2026 · strength 0.64
  7. Luis A. Pardo · 3 shared papers, 2017–2026 · strength 0.56
  8. Frauke Alves · 4 shared papers, 2016–2026 · strength 0.49
  9. Mette Flinck · 3 shared papers, 2020–2025 · strength 0.49
  10. Julie Schnipper · 3 shared papers, 2022–2026 · strength 0.49
  11. Halima Ouadid‐Ahidouch · 3 shared papers, 2022–2026 · strength 0.49
  12. Stephan J. Reshkin · 3 shared papers, 2016–2026 · strength 0.32
  13. Sofie Hagelund · 2 shared papers, 2020–2026 · strength 0.31
  14. Albrecht Schwab · 2 shared papers, 2017–2026 · strength 0.28
  15. Katrine Zeeberg · 3 shared papers, 2016–2020 · strength 0.25
  16. Rosa Angela Cardone · 2 shared papers, 2016–2026 · strength 0.25
  17. Michala G. Rolver · 1 shared paper, 2025 · strength 0.22
  18. Luís Arnes · 1 shared paper, 2025 · strength 0.22
  19. Andrea Giannuzzo · 3 shared papers, 2014–2015 · strength 0.22
  20. Su Chii Kong · 3 shared papers, 2014–2016 · strength 0.20
  21. Pawel Swietach · 1 shared paper, 2026 · strength 0.19
  22. Verena Hofschröer · 1 shared paper, 2026 · strength 0.19
  23. Laura Mezzanotte · 1 shared paper, 2026 · strength 0.19
  24. Zoltán Pethő · 1 shared paper, 2026 · strength 0.19
  25. Tiago M. A. Carvalho · 1 shared paper, 2026 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.